✦ LIBER ✦

14 PREDICTIVE VALUE OF CAIX EXPRESSION AND STAINING PATTERN IN PATIENTS WITH LARYNGEAL CANCER TREATED IN THE PHASE III RANDOMISED ARCON TRIAL

✍ Scribed by S. Rademakers; I. Hoogsteen; P. Rijken; C. Terhaard; P. Doornaert; J. Langendijk; P. Van den Ende; A.J. van der Kogel; J. Bussink; J. Kaanders

Book ID: 119519849
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 67 KB
Volume: 102
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(12)70006-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OC-0150 PREDICTIVE VALUE OF CAIX EXPRESS

OC-0150 PREDICTIVE VALUE OF CAIX EXPRESSION AND STAINING PATTERN IN PATIENTS TREATED IN THE PHASE III RANDOMISED ARCON TRIAL

✍ S. Rademakers; I. Hoogsteen; P. Rijken; C. Terhaard; P. Doornaert; J. Langendijk 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Predictive value of a proteomic signatur

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial

✍ Gregorc, Vanesa; Novello, Silvia; Lazzari, Chiara; Barni, Sandro; Aieta, Michele 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 280 KB

Prognostic and predictive value ofTP53mu

Prognostic and predictive value ofTP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial

✍ Lynnette Fernández-Cuesta, Catherine Oakman, Priscila Falagan-Lotsch, Ke-seay Sm 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 307 KB

762 Prognostic and Predictive Value of T

762 Prognostic and Predictive Value of TP53 Mutations in Node-positive Breast Cancer Patients Treated with Anthracycline-or Anthracycline/taxane Based Adjuvant Therapy – Results From the BIG 02-98 Phase III Trial

✍ M. Olivier; L. Fernández-Cuesta; C. Oakman; E. Quinaux; M.S. Dolci; P.A. Francis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 71 KB

The prognostic value of health-related q

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study

✍ Mauer, M; Stupp, R; Taphoorn, M J B; Coens, C; Osoba, D; Marosi, C; Wong, R; de 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

The Impact of EGFR T790M Mutations and B

The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial

✍ Costa, C.; Molina, M. A.; Drozdowskyj, A.; Gimenez-Capitan, A.; Bertran-Alamillo 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 651 KB